Management Review ›› 2020, Vol. 32 ›› Issue (9): 142-152.

• Technology and Innovation Management • Previous Articles     Next Articles

A Study of the Threshold Effect of R&D Intensity and the Performance of China' Listed Pharmaceutical Manufacturers

Duan Tianyu1, Zhang Xi2, Hu Yi1,3   

  1. 1. School of Economics and Management, University of Chinese Academy of Sciences, Beijing 100190;
    2. School of Economics, Beijing Technology and Business University, Beijing 100048;
    3. Key Laboratory of Big Data Mining and Knowledge Management, Chinese Academy of Sciences, Beijing 100190
  • Received:2020-01-21 Online:2020-09-28 Published:2020-09-30

Abstract: The aggravating trend of aging population makes pharmaceutical manufacturing increasingly important. Based on the panel data of 112 listed firms in Chinese pharmaceutical industry from 2012 to 2018, this paper uses a dynamic panel threshold model to explore the relationship between R&D intensity and firm performance in pharmaceutical industry. The results show that the impact of R&D intensity on firm performance is non-linear. When R&D intensity is lower and higher than 5.26%, the coefficients of R&D intensity on firm performance are 4.87 and 0.68 respectively. This paper provides decision support and data references for governments and firms to formulate relevant policies and plans. Fully considering the threshold effect of R&D intensity, firms should comprehensively formulate appropriate R&D plans based on the current range of R&D investment level, as well as policies, market, and their own conditions.

Key words: R&D intensity, firm performance, dynamic panel threshold model